This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignees: Chromadex Inc., University of California. Active years: 2014-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Orange, CA (US) (2014)
- San Marcos, CA (US) (2018)
Company Filing History:
2 out of 23 
2 out of 16,025 
Years Active: 2014-2018
Title: Innovations by Jeremy Bartos
Introduction
Jeremy Bartos is an accomplished inventor based in San Marcos, California. He has made significant contributions to the field of medical treatments, particularly in the area of cellular proliferative disorders. With a total of two patents to his name, Bartos is recognized for his innovative approaches to healthcare.
Latest Patents
Bartos's latest patents include a method for treating non-melanoma skin cancer by inducing UDP-glucuronosyltransferase activity using pterostilbene. This method provides a therapeutic approach for individuals suffering from cellular proliferative disorders by administering a therapeutically effective amount of pterostilbene, which increases UDP-glucuronosyltransferase (UGT) activity. Additionally, he has developed a method for inducing UDP-glucuronosyltransferase activity using pterostilbene, which also aims to reduce 12-HETE levels through the same compound.
Career Highlights
Throughout his career, Jeremy Bartos has worked with notable organizations such as Chromadex Inc. and the University of California. His experience in these institutions has allowed him to collaborate with other professionals and contribute to advancements in medical research.
Collaborations
Bartos has collaborated with various professionals in his field, including his coworker Ryan Dellinger. These partnerships have played a crucial role in the development of his innovative methods and patents.
Conclusion
Jeremy Bartos is a notable inventor whose work in medical treatments has the potential to impact many lives. His patents reflect a commitment to advancing healthcare through innovative solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile